Expert Pitch

Rutgers Expert Available to Discuss Risk Perception in COVID-19 Era

New Brunswick, N.J. (Oct. 26, 2020) – Rutgers University–New Brunswick Professor William Hallman is available for interviews on the science of risk perception and its practical implications in the COVID-19 era – a time of fear and anxiety among millions of people.

“The threat of COVID-19 is on everyone’s minds and rightly so, but as we wash our hands, wear masks and social distance, we shouldn’t forget about the other risks to our health,” said Hallman, an experimental psychologist who chairs the Department of Human Ecology in the School of Environmental and Biological Sciences. He is also a Rutgers Global Health Institute core faculty member. “We still need to vaccinate our kids, exercise, eat right, drive safely, floss and see a doctor when we don’t feel well. We can’t neglect all of the things necessary to prevent and treat the health and safety issues that we normally face outside of the pandemic.”

Since the 1980s, Hallman has studied public perceptions of risk involving dozens of issues, including exposure to environmental contaminants; living next to a hazardous waste dump; unexplained symptom syndromes, including chronic fatigue, multiple chemical sensitivities and Gulf War syndrome; genetically modified and gene-edited foods; organic foods; cloning; germs; avian influenza; and uptake of the flu vaccine.

He has also studied risk perception regarding nanotechnology in food and agriculture; food safety practices; food recalls; food safety risks associated with buying perishable meat, poultry, seafood and game products online and having them delivered to your home using UPS or FedEx; coastal storm evacuations; Lyme disease; power lines; and other issues related to food, air, water, agriculture, technology, public health and the environment.

Hallman is scheduled to participate in “Risky Business: The Science of Risk Perception,” a conversation with Ahmed Best, a writer, director, producer, actor, musician and futurist. The free online event is scheduled from 4 p.m. to 5 p.m. (EDT) on Wednesday, Oct. 28. It is hosted by the Science & Entertainment Exchange, a program of the National Academy of Sciences.

                                                                    ###

Broadcast interviews: Rutgers University has broadcast-quality TV and radio studios available for remote live or taped interviews with Rutgers experts. For more information, contact Neal Buccino at neal.buccino@echo.rutgers.edu

ABOUT RUTGERS—NEW BRUNSWICK
Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship is a leading public research institution and a member of the prestigious Association of American Universities. It has an internationally acclaimed faculty, 12 degree-granting schools and the Big Ten Conference’s most diverse student body.




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
2.57921